Journal Information
Share
Share
Download PDF
More article options
Review article
Uncorrected Proof. Available online 28 November 2024
Association of the C-reactive protein/albumin ratio with the prognosis of Aneurysmal Subarachnoid Hemorrhage: A systematic review
Asociación de la relación proteína C-reactiva/albumina con el pronóstico de la hemorragia subaracnoidea aneurismática: Una revisión sistemática
Gerardo Luna-Peraltaa,b, Alvaro Lopez-Luzaa,b, Claudia Cruzalegui-Bazána,b, Miguel Cabanillas-Lazoc,
Corresponding author
Mfcl2013@gmail.com

Corresponding author.
a Sociedad Cientifica de San Fernando, Lima, Peru
b Facultad de Medicina, Universidad Nacional Mayor de San Marcos, Lima, Peru
c Universidad de Huánuco, Huánuco, Peru
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Characteristics of included studies evaluating the prognostic value of CRP/albumin in patients with aneurysmal subarachnoid hemorrhage (n = 4).
Additional material (1)
Abstract

The C-Reactive Protein/Albumin Ratio (CAR) is being studied as a potential predictor of severe outcomes in various diseases. Our study aimed to review current evidence on the prognostic value of CAR in patients with aneurysmal subarachnoid hemorrhage (aSAH). We conducted a systematic search in PubMed, Embase, Scopus, Web of Science, and Google Scholar up to April 2023 and assessed the risk of bias using the NewCastle-Ottawa tool. A narrative synthesis was performed, and the GRADE system was used to evaluate the certainty of the evidence. Out of 534 articles, 4 were selected. We found that a higher CAR level is moderately associated with a lower score on the Glasgow Outcome Scale at 3 months and a higher incidence of in-hospital mortality. However, no significant association was found with the modified Rankin scale or delayed cerebral ischemia. Although the evidence is limited, CAR could be a useful tool for predicting poor prognosis in aSAH patients, but more prospective studies are needed to determine optimal cut-off points and include CAR in long-term prognostic models.

Keywords:
Subarachnoid Hemorrhage
C-Reactive Protein
Albumin
Systematic review (Source: MeSH terms)
Abbreviations:
CAR
aSAH
CRP
GOS
GCS
DCI
APRs
IL-6
TNF-alpha
NLR
Hs-CRP
TBI
WFNS
mRS
DSA
CT
NIHSS
PRISMA
GRADE
Resumen

La relación proteína C-reactiva/albumina (CAR) está siendo estudiada como un posible predictor de resultados graves en diversas enfermedades. Nuestro estudio tuvo como objetivo revisar la evidencia actual sobre el valor pronóstico de CAR en pacientes con hemorragia subaracnoidea aneurismática (HSAa). Realizamos una búsqueda sistemática en PubMed, Embase, Scopus, Web of Science y Google Scholar hasta abril de 2023 y evaluamos el riesgo de sesgo utilizando la herramienta de NewCastle-Ottawa. Se realizó una síntesis narrativa y se utilizó el sistema GRADE para evaluar la certeza de la evidencia. De 534 artículos, se seleccionaron cuatro. Encontramos que un nivel más alto de CAR está moderadamente asociado con una puntuación más baja en la Glasgow Outcome Scale a los tres meses y una mayor incidencia de mortalidad intrahospitalaria. Sin embargo, no se encontró una asociación significativa con la escala de Rankin modificada o la isquemia cerebral tardía. Aunque la evidencia es limitada, CAR podría ser una herramienta útil para predecir un mal pronóstico en pacientes con aSAH, pero se necesitan más estudios prospectivos para determinar los puntos de corte óptimos e incluir CAR en modelos pronósticos a largo plazo.

Palabras clave:
Hemorragia subaracnoidea
Proteína C-reactiva
Albúmina
Revisión sistemática (Fuente: DeCS BIREME)

Article

These are the options to access the full texts of the publication Neurocirugía (English edition)
Member
Member of the Sociedad Española de Neurocirugía

If it is the first time you have accessed you can obtain your credentials by contacting Elsevier Spain in suscripciones@elsevier.com or by calling our Customer Service at902 88 87 40 if you are calling from Spain or at +34 932 418 800 (from 9 to 18h., GMT + 1) if you are calling outside of Spain.

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option ¿I have forgotten my password¿.

Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Neurocirugía (English edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Idiomas
Neurocirugía (English edition)
Article options
Tools
Supplemental materials
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?